← Назад

Isolated permanent neonatal diabetes mellitus

ORPHA:99885DiseaseAutosomal dominant, Autosomal recessiveAntenatal, Infancy, Neonatal

Ассоциированные гены (6)

STAT3
signal transducer and activator of transcription 3
Disease-causing germline mutation(s) (gain of function) in
OMIM: 102582
GCK
glucokinase
Disease-causing germline mutation(s) in
OMIM: 138079
KCNJ11
potassium inwardly rectifying channel subfamily J member 11
Disease-causing germline mutation(s) in
OMIM: 600937
PDX1
pancreatic and duodenal homeobox 1
Disease-causing germline mutation(s) in
OMIM: 600733
INS
insulin
Disease-causing germline mutation(s) in
OMIM: 176730
ABCC8
ATP binding cassette subfamily C member 8
Disease-causing germline mutation(s) in
OMIM: 600509

Фенотипы (35)

Очень частый (80–99%)8
HP:0000857Neonatal insulin-dependent diabetes mellitus
HP:0001508Failure to thrive
HP:0001824Weight loss
HP:0001944Dehydration
HP:0003074Hyperglycemia
HP:0003076Glycosuria
HP:0006274Reduced pancreatic beta cells
HP:0011106Hypovolemia
Частый (30–79%)16
HP:0002714Downturned corners of mouth
HP:0002804Arthrogryposis multiplex congenita
HP:0002919Ketonuria
HP:0005487Prominent metopic ridge
HP:0005750Contractures of the joints of the lower limbs
HP:0012594Microalbuminuria
HP:0012758Neurodevelopmental delay
HP:0000488Retinopathy
HP:0001249Intellectual disability
HP:0001263Global developmental delay
HP:0001270Motor delay
HP:0001488Bilateral ptosis
HP:0001511Intrauterine growth retardation
HP:0001627Abnormal heart morphology
HP:0002069Bilateral tonic-clonic seizure
HP:0002123Generalized myoclonic seizure
Периодический (5–29%)10
HP:0000124Renal tubular dysfunction
HP:0000365Hearing impairment
HP:0001251Ataxia
HP:0001252Hypotonia
HP:0001259Coma
HP:0002186Apraxia
HP:0002594Pancreatic hypoplasia
HP:0003477Peripheral axonal neuropathy
HP:0010864Intellectual disability, severe
HP:0010935Abnormality of the upper urinary tract
Исключён (0%)1
HP:0030057Autoimmune antibody positivity

Эпидемиология (8)

Prevalence at birth
1-9 / 1 000 000
Europe
Point prevalence
1-9 / 1 000 000
Europe
Prevalence at birth
1-9 / 1 000 000
United Kingdom
Prevalence at birth
1-9 / 1 000 000
Poland
Prevalence at birth
1-9 / 1 000 000
Netherlands
Prevalence at birth
1-9 / 1 000 000
Slovakia
Prevalence at birth
1-9 / 1 000 000
United States
Prevalence at birth
1-5 / 10 000
Oman

Лекарства и терапия

Источник: Open Targets Platform (в реальном времени)

Клинические исследования

Источник: ClinicalTrials.gov (в реальном времени)

Внешние ресурсы